반응식
[NH2:1][C:2]1[CH:7]=[CH:6][N:5]=[CH:4][N:3]=1.N12CCN(CC1)CC2.[Cl:16][C:17]1[C:18]([F:28])=[CH:19][C:20]([F:27])=[C:21]([S:23](Cl)(=[O:25])=[O:24])[CH:22]=1>C(#N)C>[Cl:16][C:17]1[C:18]([F:28])=[CH:19][C:20]([F:27])=[C:21]([S:23]([NH:1][C:2]2[CH:7]=[CH:6][N:5]=[CH:4][N:3]=2)(=[O:25])=[O:24])[CH:22]=1참가 물질
실험 절차
A mixture of 4-aminopyrimidine (1.30 g, 13.7 mmol) and 1,4-diazabicyclo[2.2.2]octane (1.54 g, 13.7 mmol) were added concurrently to a solution of 5-chloro-2,4-difluorobenzenesulfonyl chloride (3.4 g, 14 mmol) in anhydrous acetonitrile (63 mL). The reaction mixture immediately turned yellow and a precipitate formed. The reaction mixture was stirred under argon. After 72 hours, the reaction mixture was filtered and the filtrate was concentrated in vacuo to give a residue. The residue was partitioned between 1M hydrochloric acid and ethyl acetate. The organic phase was separated, dried over anhydrous magnesium sulfate and concentrated in vacuo. The residue was partially purified by automated flash column chromatography using an 80 g silica gel ISCO™ column using hexanes to 1% v/v acetic acid in ethyl acetate gradient elution. The product was purified a second time by reverse phase HPLC to give the title compound (193 mg, 5%) as a white solid.
후처리
- customThe reaction mixture immediately turned yellow and a precipitate formed
- filtrationthe reaction mixture was filtered
- concentrationthe filtrate was concentrated in vacuo
- customto give a residue
- customThe residue was partitioned between 1M hydrochloric acid and ethyl acetate
- customThe organic phase was separated
- dry with materialdried over anhydrous magnesium sulfate
- concentrationconcentrated in vacuo
- customThe residue was partially purified by automated flash column chromatography
- washto 1% v/v acetic acid in ethyl acetate gradient elution
- customThe product was purified a second time by reverse phase HPLC
출처 및 근거
- ORD 기록
- ord-e411c3715dc34aff853b7427251500dc
- 출처 데이터셋
- uspto-grants-2013_09
- 특허 번호
- US08541588B2
연결된 노트
불러오는 중…